Veterinary Medicines

Euthasol 500 mg/ml solution for injection

Authorised
  • Pentobarbital sodium
Download as PDF

Product identification

Medicine name:
Euthasol 500 mg/ml solution for injection
Repose 500 mg/ml Oplossing voor injectie
Repose 500 mg/ml Solution injectable
Repose 500 mg/ml Injektionslösung
Active substance:
  • Pentobarbital sodium
Target species:
  • Cattle
  • Dog
  • Goat (adult female)
  • Sheep
  • Horse
  • Cat
  • Rabbit
  • Mink
  • Rodents
  • Pig
Route of administration:
  • Intracardiac use
  • Intraperitoneal use
  • Intravenous use

Product details

Active substance and strength:
  • Pentobarbital sodium
    500.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN51AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • 12 Clear Type I glass vials containing 100 ml, closed with a bromobutyl rubber stopper and aluminium cap in a carton box.
  • 12 Polypropylene vials containing 250 ml, closed with a bromobutyl rubber stopper and aluminium cap in a carton box.
  • 12 Clear Type I glass vials containing 250 ml, closed with a bromobutyl rubber stopper and aluminium cap in a carton box.
  • 1 Polypropylene vial containing 100 ml, closed with a bromobutyl rubber stopper and aluminium cap in a carton box.
  • 1 Clear Type I glass vial containing 250 ml, closed with a bromobutyl rubber stopper and aluminium cap in a carton box.
  • 1 Clear Type I glass vial containing 100 ml, closed with a bromobutyl rubber stopper and aluminium cap in a carton box.
  • 12 Polypropylene vials containing 100 ml, closed with a bromobutyl rubber stopper and aluminium cap in a carton box.
  • 1 Polypropylene vial containing 250 ml, closed with a bromobutyl rubber stopper and aluminium cap in a carton box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0320/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 20/02/2025
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 17/08/2025
Download
French (PDF)
Published on: 17/08/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 17/08/2025
Download
French (PDF)
Published on: 17/08/2025
Download
German (PDF)
Published on: 17/08/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 16/06/2025
Download
French (PDF)
Published on: 16/06/2025
Download
German (PDF)
Published on: 16/06/2025
Download